CBF leukemia and MLL-AML showed similar types of genes mutated in secondary fashion, involving signal transduction (RAS pathway and RTK cascade), IDH family, and gene transcription, of which all are essential for progressive clinical phenotypes in AML. This evidence concerns the gene KMT2A and acute myeloid leukemia.